These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 29237846)

  • 41. The control of viral infection by tripartite motif proteins and cyclophilin A.
    Towers GJ
    Retrovirology; 2007 Jun; 4():40. PubMed ID: 17565686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modular HIV-1 Capsid Assemblies Reveal Diverse Host-Capsid Recognition Mechanisms.
    Summers BJ; Digianantonio KM; Smaga SS; Huang PT; Zhou K; Gerber EE; Wang W; Xiong Y
    Cell Host Microbe; 2019 Aug; 26(2):203-216.e6. PubMed ID: 31415753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
    Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Independent evolution of an antiviral TRIMCyp in rhesus macaques.
    Wilson SJ; Webb BL; Ylinen LM; Verschoor E; Heeney JL; Towers GJ
    Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3557-62. PubMed ID: 18287035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1.
    Diaz-Griffero F; Vandegraaff N; Li Y; McGee-Estrada K; Stremlau M; Welikala S; Si Z; Engelman A; Sodroski J
    Virology; 2006 Aug; 351(2):404-19. PubMed ID: 16650449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The presence of the Trim5alpha escape mutation H87Q in the capsid of late stage HIV-1 variants is preceded by a prolonged asymptomatic infection phase.
    Kootstra NA; Navis M; Beugeling C; van Dort KA; Schuitemaker H
    AIDS; 2007 Oct; 21(15):2015-23. PubMed ID: 17885291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.
    Yap MW; Dodding MP; Stoye JP
    J Virol; 2006 Apr; 80(8):4061-7. PubMed ID: 16571822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unique features of TRIM5alpha among closely related human TRIM family members.
    Li X; Gold B; O'hUigin C; Diaz-Griffero F; Song B; Si Z; Li Y; Yuan W; Stremlau M; Mische C; Javanbakht H; Scally M; Winkler C; Dean M; Sodroski J
    Virology; 2007 Apr; 360(2):419-33. PubMed ID: 17156811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro.
    Black LR; Aiken C
    J Virol; 2010 Jul; 84(13):6564-9. PubMed ID: 20410272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caging the beast: TRIM5α binding to the HIV-1 core.
    Diaz-Griffero F
    Viruses; 2011 May; 3(5):423-8. PubMed ID: 21994740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association.
    Li X; Sodroski J
    J Virol; 2008 Dec; 82(23):11495-502. PubMed ID: 18799578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.
    Twizerimana AP; Scheck R; Becker D; Zhang Z; Wammers M; Avelar L; Pflieger M; Häussinger D; Kurz T; Gohlke H; Münk C
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles.
    Ylinen LM; Keckesova Z; Wilson SJ; Ranasinghe S; Towers GJ
    J Virol; 2005 Sep; 79(18):11580-7. PubMed ID: 16140735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
    Stremlau M; Owens CM; Perron MJ; Kiessling M; Autissier P; Sodroski J
    Nature; 2004 Feb; 427(6977):848-53. PubMed ID: 14985764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding.
    Javanbakht H; Yuan W; Yeung DF; Song B; Diaz-Griffero F; Li Y; Li X; Stremlau M; Sodroski J
    Virology; 2006 Sep; 353(1):234-46. PubMed ID: 16808955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of TRIM5α in vivo.
    Nakayama EE; Shioda T
    AIDS; 2015 Sep; 29(14):1733-43. PubMed ID: 26372380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids.
    Li YL; Chandrasekaran V; Carter SD; Woodward CL; Christensen DE; Dryden KA; Pornillos O; Yeager M; Ganser-Pornillos BK; Jensen GJ; Sundquist WI
    Elife; 2016 Jun; 5():. PubMed ID: 27253068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells.
    Hatziioannou T; Perez-Caballero D; Cowan S; Bieniasz PD
    J Virol; 2005 Jan; 79(1):176-83. PubMed ID: 15596813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
    Keckesova Z; Ylinen LM; Towers GJ
    J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
    Berthoux L; Sebastian S; Sayah DM; Luban J
    J Virol; 2005 Jun; 79(12):7883-8. PubMed ID: 15919943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.